PRGS:NASDAQProgress Software Corporation Analysis
Data as of 2026-05-19 - not real-time
$28.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Progress Software (PRGS) is trading at $28.90, just above its 20‑day SMA of $28.24 but below both the 50‑day ($29.36) and 200‑day ($39.42) averages, indicating a short‑term pullback within a longer‑term bearish backdrop. The RSI sits at 50.7, suggesting neutral momentum, while the MACD histogram is positive (+0.166) after a recent bullish crossover, hinting at a potential technical bounce toward the $30.77 resistance. Fundamentally, the stock appears deeply undervalued – the DCF fair‑value estimate of $61.13 implies roughly a 75% upside, and the forward PE of 4.77 is far below the industry average PE of 38, reflecting strong earnings growth expectations (forward EPS $6.06 vs trailing $1.95). Margins remain robust with 85% gross and 20% operating margins, and free cash flow of $247 M supports the business despite a high debt‑to‑equity ratio of 276% and modest cash reserves of $113 M. The company’s recent AI‑focused product launches and expansion of its Bengaluru innovation hub provide a clear growth catalyst, while the overall market sentiment is extremely bullish (Fear‑Greed Index 89, “Extreme Greed”).
Given the 30‑day volatility of 56% and a decreasing volume trend, the stock is susceptible to short‑term swings, but the combination of substantial valuation upside, solid profitability, and strategic AI positioning supports a longer‑term investment thesis. Investors should weigh the high leverage and recent drawdown of 61% against the attractive valuation and growth narrative, making a cautious but optimistic case for accumulation over the medium to long horizon.
Given the 30‑day volatility of 56% and a decreasing volume trend, the stock is susceptible to short‑term swings, but the combination of substantial valuation upside, solid profitability, and strategic AI positioning supports a longer‑term investment thesis. Investors should weigh the high leverage and recent drawdown of 61% against the attractive valuation and growth narrative, making a cautious but optimistic case for accumulation over the medium to long horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near immediate support at $25.96
- Bearish longer‑term trend with price below 200‑day SMA
- High short‑term volatility and decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside of ~75% and forward PE of 4.77
- Strong operating margins and growing free cash flow
- Strategic AI product expansion and new innovation hub
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained undervaluation relative to industry peers
- Long‑term AI market tailwinds supporting revenue growth
- Robust profitability despite high leverage, with potential deleveraging as cash generation improves
Key Metrics & Analysis
Financial Health
Revenue Growth4.10%
Profit Margin8.61%
P/E Ratio14.8
ROE18.27%
ROA4.66%
Debt/Equity275.77
P/B Ratio2.4
Op. Cash Flow$264.9M
Free Cash Flow$247.7M
Industry P/E38.0
Technical Analysis
TrendBearish
RSI50.7
Support$25.96
Resistance$30.77
MA 20$28.24
MA 50$29.36
MA 200$39.42
MACDBullish
VolumeDecreasing
Fear & Greed Index89.04
Valuation
Fair Value$61.13
Target Price$50.83
Upside/Downside75.92%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.92
Volatility55.97%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.